J Clin Psychiatry

1. DAMME KSF, Mittal VA
   Exercise Reduces Dysphoria in Clinical High Risk for Psychosis: A Randomized Controlled Trial.
   J Clin Psychiatry. 2026;87:25br16079.
   

   >> Share

   
   

   
   Mol Psychiatry

2. LEMKE JR, Eoli A, Krey I, Popp B, et al
   Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.
   Mol Psychiatry. 2026 Jan 7. doi: 10.1038/s41380-025-03442.
   

   >> Share

   
   

   
   Nature

3. GROTZINGER AD, Werme J, Peyrot WJ, Frei O, et al
   Mapping the genetic landscape across 14 psychiatric disorders.
   Nature. 2026;649:406-415.
   

   >> Share

   
   

   
   PLoS One

4. REN H, Yang Q, He C, Jiao J, et al
   Community management: An effective model to reduce medication discontinuation rate in patients with schizophrenia.
   PLoS One. 2026;21:e0324114.
   

   >> Share

   
   
5. RENWICK L, Brooks H, Keliat BA, Wulandari D, et al
   Delivering culturally adapted family interventions for people with schizophrenia in Indonesia: A feasibility randomised controlled trial and nested process evaluation.
   PLoS One. 2026;21:e0338371.
   

   >> Share

   
   

   
   Psychol Med

6. TOUTOUNTZIDIS D, Ricketts E, Laws KR
   Trauma-focused psychological interventions for psychosis: Meta-analytic evidence of differential effects on delusions and hallucinations.
   Psychol Med. 2026;56:e11.
   

   >> Share

   
   

   
   Schizophr Res

7. CHAN A, Lu A, Menon T, Wong S, et al
   Association between negative symptoms and health-related quality of life and functional outcomes in persons with schizophrenia: A systematic review.
   Schizophr Res. 2026;288:95-103.
   

   >> Share

   
   
8. KAUL I, Claxton A, Chaturvedi S, Patel T, et al
   Long-term efficacy, safety, and tolerability of xanomeline and trospium chloride in schizophrenia: A 52-week, open-label trial (EMERGENT-5).
   Schizophr Res. 2026;288:86-94.
   

   >> Share

   
   
9. NEFF MA, Raffensperger KV, Moore RC, Depp CA, et al
   Predictions of different elements of everyday functional outcomes in bipolar disorder and schizophrenia: Cognition, social cognition, clinical symptoms, and mood states as predictors.
   Schizophr Res. 2026;288:77-85.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share